Dietary Ethyl-eicosapentaenoic Acid but not Soybean Oil Reverses Central Interleukin-1-induced Changes in Behavior, Corticosterone and Immune Response in Rats

Stress

Volumn 7, Issue 1, 2004, Pages 43-54

  Song, Cai ^a   Leonard, Brian E ^b   Horrobin, David F ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Laxdale Ltd   (United Kingdom)

Author keywords

Anxiety; Corticosterone; Elevated plus maze; Ethyl EPA; IL 1 ; IL 10

Indexed keywords

COCONUT OIL; CORTICOSTERONE; ICOSAPENTAENOIC ACID ETHYL ESTER; INTERLEUKIN 1; PROSTAGLANDIN E2; SOYBEAN OIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DIETARY INTAKE; EVALUATION; FEEDING; FOOD; HEALTH STATUS; IMMUNE RESPONSE; LEUKOCYTE; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STRESS; WEIGHT REDUCTION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BODY WEIGHT; CORTICOSTERONE; DIETARY FATS; DINOPROSTONE; DRUG INTERACTIONS; EICOSAPENTAENOIC ACID; IMMUNE SYSTEM; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; INTERLEUKIN-10; MALE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; SOYBEAN OIL; STRESS, PSYCHOLOGICAL;

EID: 1842810986     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.1080/10253890410001667188     Document Type: Article

References (77)

1. Adams, P.B., Lawson, S., Sanigorski, A. and Sinclair, A.J. (1996) Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression, Lipids 31, S157-S161.
2. Aharoni, R., Teitelbaum, D., Leitner, O., Meshorer, A., Sela, M. and Amon, R. (2000) Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1, Proc. Natl Acad. Sci. USA 97, 11472-11477.
3. Bank, W.A. (1999) Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders, J. Neurovirol. 5, 538-555.
4. Belzung, C. and Griebel, G. (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review, Behav. Brain Res. 125, 141-149.
5. Blok, W.L., Katan, M.B. and van der Meer, J.W. (1996) Modulation of inflammation and cytokine production by dietary (n-3) fatty acids, J. Nutr. 126, 1515-1533.
6. Bluthe, R.M., Dantzer, R. and Kelley, K.W. (1997) Central mediation of the effects of interleukin-1 on social exploration and body weight in mice, Psychoneuroendocrinology 22, 1-11.
7. Brown, R., Li, Z., Vriend, C.Y., Nirula, R., Janz, L., Falk, J., Nance, D.M., Dyck, D.G. and Greenberg, A.H. (1991) Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1 beta: evidence for pituitary-adrenal and sympathetic control, Cell. Immunol. 132, 84-93.
8. Calder, P.C. (2001) Polyunsaturated fatty acids, inflammation, and immunity, Lipids 36, 1007-1024.
9. Carrie, I., Guesnet, P., Bourre, J.M. and Frances, H. (2000a) Diets containing long-chain n-3 polyunsaturated fatty acids affect behaviour differently during development than ageing in mice, Br. J. Nutr. 83, 439-447.
10. Carrie, I., Clement, M., de Javel, D., Frances, H. and Bourre, J.M. (2000b) Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice, J. Lipid Res. 41, 473-480.
11. Chalon, S., Delion-Vancassel, S., Belzung, C., Guilloteau, D., Leguisquet, A.M., Besnard, J.C. and Durand, G. (1998) Dietary fish oil affects monoaminergic neurotransmission and behavior in rats, J. Nutr. 128, 2512-2519.
12. Chen, G. and Reichlin, S. (1999) Mechanisms by which blood levels of interleukin-6 (IL-6) are elevated after intracerebroventricular injection of IL-1beta in the rat: neural versus humoral control, Endocrinology 140, 5549-5555.
13. Connor, W.E. (1997) The beneficial effects of omega-3 fatty acids: cardiovascular disease and neurodevelopment, Curr. Opin. Lipidol. 8, 1-3.
14. Connor, T.J., Song, C., Leonard, B.E., Merali, Z. and Anisman, H. (1998) An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat, Neuroscience 84, 923-933.
15. Crusio, W.E. (2001) Genetic dissection of mouse exploratory behaviour, Behav. Brain Res. 125, 127-132.
16. Dantzer, R. (2001) Cytokine-induced sickness behavior: mechanisms and implications, Ann. N. Y. Acad. Sci. 933, 222-234.
17. De Pablo, M.A. and De Cienfuegos, G.A. (2000) Modulatory effects of dietary lipids on immune system functions, Immunol. Cell. Biol. 78, 31-39.
18. Dunn, A.J. (1993) Infection as a stressor: a cytokine-mediated activation of the hypothalamo-pituitary-adrenal axis?, Ciba Found. Symp. 172, 226-239.
19. Edwards, R., Peet, M., Shay, J. and Horrobin, D. (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients, J. Affect. Disord. 48, 149-155.
20. Engblom, D., Ek, M., Saha, S., Ericsson-Dahlstrand, A., Jakobsson, P.J. and Blomqvist, A. (2002) Prostaglandins as inflammatory messengers across the blood-brain barrier, J. Mol. Med. 80, 5-15.
21. Ek, M., Arias, C., Sawchenko, P. and Ericsson-Dahlstrand, A. (2000) Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness, J. Comp. Neurol. 428, 5-20.
22. Ericsson, A., Arias, C. and Sawchenko, P.E. (1997) Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1, J. Neurosci. 17, 7166-7179.
23. Ferrarese, C., Mascarucci, P., Zoia, C., Cavarretta, R., Frigo, M., Begni, B., Sarinella, F., Frattola, L. and De Simoni, M.G. (1999) Increased cytokine release from peripheral blood cells after acute stroke, J. Cereb. Blood Flow Metab. 19, 1004-1009.
24. File, S.E. (2001) Factors controlling measures of anxiety and responses to novelty in the mouse, Behav. Brain Res. 125, 151-157.
25. Furse, R.K., Rossetti, R.G. and Zurier, R.B. (2001) Gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, blocks amplification of IL-1 beta production by human monocytes, J. Immunol. 167, 490-496.
26. Gray, J.A. and Lalljee, B. (1974) Sex differences in emotional behaviour in the rat: correlation between open-field defecation and active avoidance, Anim. Behav. 22, 856-861.
27. Hamazaki, T., Sawazaki, S., Nagasawa, T., Nagao, Y., Kanagawa, Y. and Yazawa, K. (1999) Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress, Lipids 34, S33-S37.
28. Hamazaki, T., Itomura, M., Sawazaki, S. and Nagao, Y. (2000) Antistress effects of DHA, Biofactors 13, 41-45.
29. Hargreaves, K.M. and Clandinin, M.T. (1988) Dietary control of diacylphosphatidylethanolamine species in brain, Biochim. Biophys. Acta 962, 98-104.
30. Harrison, R.A. and Harrison, B.J. (2001) Fish oils are beneficial to patients with established rheumatoid arthritis, J. Rheumatol. 28, 2563-2565.
31. Hauss-Wegrzyniak, B., Lukovic, L., Bigaud, M. and Stoeckel, M.E. (1998) Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study, Brain Res. 794, 211-224.
32. Horrobin, D.F. (1999) The phospholipids concept of sychiatric disorders and its relationship to the neurodevelopmental concept of schizophrenia, In: Peet, M., Glen, I. and Horrobin, D.F., eds, Phospholipid Spectrum Disorder in Psychiatry (Marius Press, Lancashire, UK), pp 3-20.
33. Horrobin, D.F. and Bennett, C.N. (1999a) Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes, Prostaglandins Leukot. Essent. Fatty Acids 60, 217-234.
34. Horrobin, D.F. and Bennett, C.N. (1999b) New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism, Prostaglandins Leukot. Essent. Fatty Acids 60, 141-167.
35. Horrobin, D.F., Jenkins, K., Bennett, C.N. and Christie, W.W. (2002) Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding, Prostaglandins Leukot. Essent. Fatty Acids 66, 83-90.
36. Ikemoto, A., Nitta, A., Furukawa, S. and Ohishi, M. (2000) Dietary n-3 dietary deficiency decreases nerve growth factor content in rat hippocampus, Neurosci. Lett. 285, 99-102.
37. Ilzecka, J. (2003) Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients, Acta Neurol. Scand. 108, 125-129.
38. James, M.J., Gibson, R.A. and Cleland, L.G. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production, Am. J. Clin. Nutr. 71, S343-348S.
39. Jakobsson, P.J., Thoren, S., Morgenstern, R. and Samuelsson, B. (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc. Natl Acad. Sci. USA 96, 7220-7225.
40. Kastin, A.J., Pan, W., Maness, L.M. and Banks, W.A. (1999) Peptides crossing the blood-brain barrier: some unusual observations, Brain Res. 848, 96-100.
41. Kim, H.Y., Akbar, M., Lau, A. and Edsall, L. (2000) Inhibition of neural apoptosis by DHA (22:6n-3): role of phosphatidyl serine in antiapoptotic effect, J. Biol. Chem. 351, 709-716.
42. Kitajka, K., Puskas, L.G., Zvara, A., Hackler, Jr, L., Barcelo-Coblijn, G., Yeo, Y.K. and Farkas, T. (2002) The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids, Proc. Natl Acad. Sci. USA 99, 2619-2624.
43. Koob, G.F., Heinrichs, S.C., Pich, E.M., Menzaghi, F., Baldwin, H., Miczek, K. and Britton, K.T. (1993) The role of corticotropin-releasing factor in behavioural responses to stress, Ciba Found. Symp. 172, 277-289.
44. Kozak, W., Soszynski, D., Rudolph, K., Conn, C.A. and Kluger, M.J. (1997) Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation, Am. J. Physiol. 272, R1298-R1307.
45. Lacosta, S., Merali, Z. and Anisman, H. (1998) Influence of interleukin-1 beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice, Psychopharmacology 137, 351-361.
46. Lieb, J., Karmali, R. and Horrobin, D. (1983) Elevated levels of prostaglandin E2 and thromboxane B2 in depression, Prostaglandins Leukot. Med. 10, 361-367.
47. Lucey, D.R., Clerici, M. and Shearer, G.M. (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases, Clin. Microbiol. Rev. 9, 532-562.
48. Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R. and Meltzer, H. (1996) Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids, J. Affect. Disord. 38, 35-46.
49. Maes, M., Christophe, A., Bosmans, E., Lin, A. and Neels, H. (2000) In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress, Biol. Psychiatry 47, 910-920.
50. Marangell, L.B., Martinez, J.M., Zboyan, H.A., Kertz, B., Kim, M.F. and Puryear, L.J. (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression, Am. J. Psychiatry 160, 996-998.
51. Mantzioris, E., Cleland, L.G., Gibson, R.A., Neumann, M.A., Demasi, M. and James, M.J. (2000) Biochemical effects of a diet containing foods enriched with n-3 fatty acids, Am. J. Clin. Nutr. 72, 42-48.
52. Meydani, S.N., Lichtenstein, A.H., Cornwall, S., Meydani, M., Goldin, B.R., Rasmussen, H., Dinarello, C.A. and Schaefer, E.J. (1993) Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment, J. Clin. Investig. 92, 105-113.
53. Nemets, B., Stahl, Z. and Belmaker, R.H. (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder, Am. J. Psychiatry 159, 477-479.
54. Otsuka, M. (2000) Analysis of dietary factors in Alzheimer's disease: clinical use of nutritional intervention for prevention and treatment of dementia, Nippon Ronen Igakkai Zasshi 37, 970-973.
55. Pellow, S., Chopin, P., File, S.E. and Briley, M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods 14, 149-167.
56. Peet, M. and Horrobin, D.F. (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs, Arch. Gen. Psychiatry 59, 913-919.
57. Peet, M., Murphy, B., Shay, J. and Horrobin, D. (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients, Biol. Psychiatry 43, 315-319.
58. Peet, M., Brind, J., Ramchand, C.N., Shah, S. and Vankar, G.K. (2001) Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia, Schizophr. Res. 49, 243-251.
59. Plata-Salaman, C.R., Sonti, G., Borkoski, J.P., Wilson, C.D. and French-Mullen, J.M. (1996) Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations, Physiol. Behav. 60, 867-875.
60. Rogers, J.T., Leiter, L.M., McPhee, J., Cahill, C.M., Zhan, S.S., Potter, H. and Nilsson, L.N. (1999) Translation of the Alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences, J. Biol. Chem. 274, 6421-6431.
61. Romagnani, S. (1995) Biology of human TH1 and TH2 cells, J. Clin. Immunol. 15, 121-129.
62. Saperstein, A., Brand, H., Audhya, T., Nabriski, D., Hutchinson, B., Rosenzweig, S. and Hollander, C.S. (1992) Interleukin Ibeta mediates stress-induced immunosuppression via corticotropin-releasing factor, Endocrinology 130, 152-158.
63. Schnell, L., Fearn, S., Schwab, M.E., Perry, V.H. and Anthony, D.C. (1999) Cytokine-induced acute inflammation in the brain and spinal cord, J. Neuropathol. Exp. Neurol. 58, 245-254.
64. Salem, N. (1989) Omega 3 fatty acids: molecular and biochemical aspects, In: Spiller, G.A. and Scala, J., eds, New Roles for Selective Nutrients (Alan R. Liss, New York), pp 109-228.
65. Song, C. (2000) The interaction between cytokines and neurotransmitters in depression and stress: possible mechanism of antidepressant treatment, Human Psychopharmacol. Clin. Exp. 15, 199-211.
66. Song, C. (2002) The effect of thymectomy and IL-1 on memory: implications for the relationship between immunity and depression, Brain Behav. Immun. 16, 557-568.
67. Song, C., Earley, B. and Leonard, B.E. (1995) Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress?, Ann. N. Y. Acad. Sci. 771, 55-72.
68. Song, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E. and Scharpe, S. (1998) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression, J. Affect. Disord. 49, 211-219.
69. Song, C., Merali, Z. and Anisman, H. (1999) Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment, Neuroscience 88, 823-836.
70. Song, C., Han, C., Halbreich, U., Leonard, B.E., Meng, F., Lou, H.C., Zhou, D.F. and Shen, Y.C. (2002) Effects of electronic acupuncture and fluoxetine treatments on plasma concentrations of pro- and anti-inflammatory cytokines in normal controls and depressed patients, Official Publication of the American College of Neuropsychopharmacology, 93, Abstract.
71. Song, C., Li, X., Leonard, B.E. and Horrobin, D.F. (2003) Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats, J. Lipid Res. 44, 1984-1991.
72. Venkatraman, J.T. and Chu, W.C. (1999) Effects of dietary omega-3 and omega-6 lipids and vitamin E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model for rheumatoid arthritis, J. Am. Coll. Nutr. 18, 602-613.
73. Voigt, P.G., Llorente, A., Jensen, C. and Berretta, M.C. (1998). Preliminary results of a placebo controlled of essential fatty acids trial in attention deficit hyperactivity disorder, NIH workshop on omega 3 essential fatty acids and psychiatric disorders. pp. 24.
74. Watkins, P.A., Hamilton, J.A., Leaf, A., Spector, A.A., Moore, S.A., Anderson, R.E., Moser, H.W., Noetzel, M.J. and Katz, R. (2001) Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases, J. Mol. Neurosci. 16, 87-92.
75. Ye, S.M. and Johnson, R.W. (2001) An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice, Neuroimmunomodulation 9, 183-192.
76. Yokotani, K., Wang, M., Murakami, Y., Okada, S. and Hirata, M. (2000) Brain phospholipase A (2)-arachidonic acid cascade is involved in the activation of central sympatho-adrenomedullary outflow in rats, Eur. J. Pharmacol. 398, 341-347.
77. Zhang, J. and Revist, S. (1999) Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation, Eur. J. Neurosci. 11, 2651-2668.